logo
    • English
      • 简体中文
      • 繁體中文
  • Home
  • Articles
    • Insights
    • Client Press Releases
    • Client Coverage
  • Interviews
    • CEO Interview
    • PDAC Interview
  • Clients
    • Featured Companies
    • In-depth Analysis
  • Markets
    • Stock Tracker
    • Markets at a glance
    • Investing 101
      • Investing in Mining 101
        • Gold and Precious Metals
        • Electric and Battery Metals
        • Base Metals
        • Other Mining Subsectors
  • METALS 100
  • GCFF Event
    • Next Event
    • Past Events
  • Home
  • Biotechnology
Filter

Biotechnology

Categories

Sectors

Locations

Exchange

医疗保健精选——Itamar拟发售3000万美元ADS,Hepion Pharma取得积极NASH数据

Healthcare Roundup  – Itamar -4.7% after filing for $30M ADS offering, Hepion Pharma +46% on positive NASH data

Jan 28, 2020

Life Science

Naturally Splendid Signs Agreement with Northridge Sales Group

Jan 28, 2020

Life Science

Technology Roundup – Guidewire gains a rare bear, Apple shares hit by China’s coronavirus worries

Jan 27, 2020

Life Science

控制冠状病毒爆发,中国科学家全力以赴

Chinese Scientists Provide Support to Control Coronavirus Outbreak

Jan 27, 2020

Life Science

TILT Biotherapeutics签约中国普米斯生物,用TILT-123治疗癌症

TILT Biotherapeutics Signs a Licensing Deal with Biotheus, Inc for Cancer Therapy with Oncolytic Virus TILT-123

Jan 27, 2020

Life Science

Sorrento Therapeutics拒绝了价值近10亿美元的收购报价

Sorrento Therapeutics Rejects Acquisition Bid Worth Nearly $1 Billion

Jan 27, 2020

Life Science

基石药业

CStone announces first patient dosed in the global proof-of-concept study of CS1001 in combination with Bayer’s regorafenib

Jan 24, 2020

Life Science

医疗保健精选——Innovative Industrial Properties公开发行,拜耳减持CRISPR Therapeutics股份

Healthcare Roundup – Innovative Industrial Properties prices public offering, Bayer cuts stake in CRISPR Therapeutics

Jan 24, 2020

Life Science

默克的Keytruda迎挑战,百济神州Tislelizumab鳞状非小细胞肺癌

BeiGene’s Tislelizumab Could Challenge Merck’s Keytruda in the Checkpoint Inhibitor Market

Jan 24, 2020

Life Science

Naturally Splendid Terminates Agreements

Jan 24, 2020

Life Science

宝洁监测中国冠状病毒

Procter & Gamble says it is monitoring China coronavirus and its impact on travel, consumer confidence

Jan 23, 2020

Life Science

歌禮製藥ASC22有望成為HBV一流免疫療法

Ascletis Received Approval of Clinical Trials in HBV Patients for ASC22, a Subcutaneously Administered PD-L1 Antibody

Jan 23, 2020

Life Science

中美Oncologie开展胃癌精准医学计划

Genialis and Oncologie Collaborate on Precision Medicine Initiative in Gastric Cancer

Jan 23, 2020

Life Science

医疗保健 Nextleaf获得第二份许可证,Tivity Health与沃尔玛达成交易

Healthcare Roundup – Nextleaf nabs second license, Tivity Health inks deal with Walmart

Jan 23, 2020

Life Science

和黄医药,默克扩大了许可协议

Healthcare Roundup – Chi-Med readies $110M, Merck expands licensing agreement

Jan 22, 2020

Life Science

Eastwood Bio-Medical Canada Inc. Reflects on 2019 Progress, Announces New Products and Chinese and Taiwanese Partnerships

Jan 21, 2020

Life Science

专注女性健康的Mycovia Pharmaceuticals管理层“换血”

Mycovia Pharmaceuticals Expands Commercialization Team with Strategic New Hires

Jan 21, 2020

Life Science

医疗保健精选—— 再鼎医药股票发行,礼来公司投资北卡罗来纳州工厂

Healthcare Roundup – Zai Lab launches equity offering, Lilly to invest $470M in North Carolina site

Jan 21, 2020

Life Science

  • ‹‹ Previous
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • Next ››

We connect Investors to Opportunities.

Financial Market Data copyright © 2020 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

 
QuoteMedia logo

Head Office

  • 2209 – 1111 Alberni Street
    Vancouver, BC Canada V6E 4V2
  • Phone: (604) 488-8878
  • Fax: (604) 488-0868
  • Toll Free: 1 (866) 833-5517
  • Email: [email protected]

Shanghai Office

  • 06 - 607, 6/f. No.800 Shangcheng
    Road Pudong New District Shanghai,
    China
  • Phone: 021-68883919
  • Fax: 021-68882879
  • Email: [email protected]

Important Links

  • Privacy Policy
  • Terms of Use
  • Content Partner
  • NAI500 Investor Relations Services
  • About Us
  • Contact Us

© 2026 NAI Interactive Ltd. All Rights Reserved

gcff

logo

Website Design Vancouver by Nirvana Canada